Previously, these cells were found in higher numbers in patients in unstable angina or acute myocardial infarction in peripheral blood and tissue samples which contributed to clinical interest for CD31 as potential therapeutic target.[13], [39], [40], [41]. Here, PECAM1 is linked to myocardial infarction.